revascularization strategies for patients with T2DM.
Among others, age, duration of T2DM, insulin treatment, and complexity of coronary disease are oft-cited high-risk features. There are 2 equally plausible hypotheses related to the treatment effect of CABG relative to T2DM, multivessel disease, and highrisk markers. The first is that CABG versus PCI would have greatest benefit in T2DM patients with higherrisk features, following the principal that the highestrisk patients benefit greatest from effective therapies. An equally compelling hypothesis is that the presence of T2DM requiring insulin treatment represents such a high-risk status in patients with multivessel disease that the competing risk of comorbid conditions could to some degree attenuate the benefit of CABG over PCI. Therefore, CABG versus PCI outcomes could be more comparable in both absolute and relative terms, independent of other proven prognostic factors such as the SYNTAX score, age, or T2DM duration. This is the crux of the importance of the present analyses by Dangas et al. (1).
CONTEXT WITH PRIOR LITERATURE
It is important to place the results of the present 
SYNTAX SCORE
Results from the FREEDOM and SYNTAX trials suggest greater treatment benefit of CABG versus PCI with increasing complexity of coronary artery disease (3).
In the original FREEDOM report, the HR was numerically lower in the patients with a SYNTAX score of #22 versus a score of >22 (1.14 vs. 
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